Generic medicine

Empagliflozin 25mg Tablet

Reviewed educational reference: what Empagliflozin is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.

Reviewed by Sohan Lal Kushwaha
Molecule
Empagliflozin
Strength
25mg
Dosage form
Tablet
Drug class
SGLT2 Inhibitor

Related products

No reviewed products are currently published for this generic.

Empagliflozin is a selective inhibitor of the sodium-glucose co-transporter 2. This protein is found in the kidneys and helps the body reabsorb glucose from the urine. By blocking this process, Empagliflozin 25mg Tablet allows more sugar to leave the body through urination. This action lowers blood glucose levels without needing more insulin. It is also used to protect the heart and kidneys in patients with chronic conditions.

At a glance

Quick look

A selective SGLT2 inhibitor.

How it works

It lowers blood glucose by promoting the excretion of glucose through urine.

Who it is for

It is used to manage type 2 diabetes and reduce the risk of heart failure hospitalization.

Uses it for
Type 2 DiabetesHeart Failure (HFrEF)Heart Failure (HFpEF)Chronic Kidney DiseaseCardiovascular Risk ReductionGlycemic Control

Uses of Empagliflozin

  • Management of type 2 diabetes mellitus.
  • Reduction of cardiovascular death in patients with type 2 diabetes.
  • Treatment of heart failure with reduced ejection fraction.
  • Treatment of heart failure with preserved ejection fraction.
  • Slowing the progression of chronic kidney disease.
  • Reducing the risk of hospitalization for heart failure.

Benefits of Empagliflozin

Cardiovascular Protection. Empagliflozin 25mg Tablet provides significant benefits for the heart. It reduces the risk of heart failure and cardiovascular death in patients with type 2 diabetes. This makes it a preferred choice for those with high cardiac risk.

Weight and Blood Pressure. Empagliflozin often leads to modest weight loss and a slight drop in blood pressure. This happens because glucose and sodium are lost in the urine, which reduces fluid retention in the body.

Side effects of Empagliflozin

The most common side effects of Empagliflozin 25mg Tablet are related to the increase in sugar in the urine. This creates an environment where yeast and bacteria can grow, leading to genital mycotic infections or urinary tract infections. Some patients may experience increased urination, which can lead to dehydration or a drop in blood pressure, causing dizziness. A rare but serious side effect is euglycemic ketoacidosis, where the blood becomes acidic even though blood sugar levels appear normal. Other possible effects include nausea, thirst, and a general feeling of weakness due to volume depletion.

Side effectHow commonHow severeWhat to do
Genital mycotic infectionVery commonMildMaintain strict genital hygiene.
Urinary tract infectionCommonModerateIncrease daily fluid intake.
Volume depletionCommonModerateReduce dose of other diuretics.

How to manage side effects

Genital mycotic infection

  • Clean area daily
  • Use antifungal cream
  • Consult doctor if persistent

Urinary tract infection

  • Drink more water
  • Complete antibiotic course
  • Monitor for fever

Volume depletion

  • Monitor weight
  • Increase water intake
  • Report dizziness

How to use Empagliflozin

  • Take Empagliflozin 25mg Tablet strictly as directed by your prescribing physician.
  • Take Empagliflozin 25mg Tablet once every single day by mouth.
  • You can take this medication with or without food.
  • Try to take it at the same time each morning to maintain a steady level in your body.
  • Swallow the tablet whole with a full glass of water. Do not crush, split, or chew the tablet.
  • Keep track of your daily fluid intake and ensure you stay well hydrated throughout your treatment course.

Special population advice

Kidney impairment

  • Avoid starting Empagliflozin 25mg Tablet if eGFR is below 20 mL/min/1.73m2.
  • Monitor renal function closely during treatment.

Liver impairment

  • No dose adjustment is required for patients with hepatic impairment.

Children

  • Safety and efficacy in children under 18 years are not established.
  • Not recommended for pediatric use.

Elderly

  • Monitor closely for volume depletion and hypotension.
  • Adjust diuretic doses if necessary to avoid dehydration.

How Empagliflozin works

Empagliflozin works by blocking the SGLT2 protein in the proximal tubules of the kidneys. Normally, this protein reabsorbs glucose back into the bloodstream. By inhibiting this process, Empagliflozin 25mg Tablet forces the kidneys to excrete excess glucose through the urine. This lowers the overall blood glucose level without increasing insulin secretion, which also reduces the risk of hypoglycemia when used alone.

What if you miss or exceed a dose?

If you miss a dose

If you forget a dose of Empagliflozin 25mg Tablet, take it as soon as you remember. If it is almost time for your next dose, skip the missed one. Do not take two doses at once to make up for a missed one, as this may increase the risk of side effects.

In case of overdose

Taking too much Empagliflozin can lead to severe dehydration or very low blood pressure. You may feel dizzy, faint, or experience extreme thirst. Seek medical help immediately if you suspect an overdose of Empagliflozin 25mg Tablet to receive supportive care.

Antidoteno specific antidote

Treatment is supportive and symptomatic.

Fluid Replacement
Administer intravenous fluids to correct dehydration and restore blood volume.
Blood Pressure
Monitor for hypotension and provide hemodynamic support if needed.
Glucose Monitoring
Check for euglycemic ketoacidosis and monitor blood ketones.
Electrolyte Balance
Correct any imbalances caused by osmotic diuresis.

Safety and precautions

When to avoid Empagliflozin

Do not take if you
  • Hypersensitivity

    Severe allergic reaction to Empagliflozin or any tablet excipients.

  • Severe Renal Failure

    Not recommended if eGFR is below 20 mL/min/1.73m2.

Use with caution
  • History of DKA

    Increased risk of euglycemic ketoacidosis, especially during illness.

  • Volume depletion

    Risk of hypotension and acute kidney injury in dehydrated patients.

  • Urinary tract infections

    Higher incidence of recurrent UTIs in predisposed individuals.

  • Concurrent diuretic use

    Potential for excessive fluid loss and severe hypotension.

Safety at a glance

AlcoholUse with caution

Limit alcohol intake as it can increase the risk of dehydration and ketoacidosis.

PregnancyUnsafe

Do not use during pregnancy due to lack of safety data and potential fetal harm.

BreastfeedingUnsafe

Avoid use during breastfeeding as it is unknown if the drug passes into breast milk.

DrivingSafe

Generally safe, but be cautious if you feel dizzy due to low blood pressure.

KidneyUse with caution

Monitor eGFR regularly. Dose adjustment or discontinuation may be needed if kidney function drops.

LiverSafe

No dose adjustment is typically required for patients with liver impairment.

AllergyUnsafe

Do not take if you have a known hypersensitivity to Empagliflozin.

ChildrenConsult your doctor

Not approved for use in children or adolescents under 18 years of age.

ElderlyUse with caution

Use with care as elderly patients are more susceptible to dehydration and hypotension.

Interactions

With other medicines

Insulin

Moderate

Changes the medicine’s effect

What can happen: Increased risk of hypoglycemia.

What to do: Reduce the dose of insulin as needed.

Loop Diuretics

Moderate

Changes the medicine’s effect

What can happen: Increased risk of volume depletion and hypotension.

What to do: Adjust diuretic dose and monitor fluid status.

Sulfonylureas

Moderate

Changes the medicine’s effect

What can happen: Increased risk of hypoglycemia.

What to do: Reduce the dose of the sulfonylurea.

With food and drink

  • High sugar foodsModerate

    Excessive intake of simple sugars reduces the efficacy of blood glucose lowering.

  • AlcoholModerate

    Alcohol consumption can exacerbate the risk of dehydration and ketoacidosis.

If you have another condition

  • Severe Renal Impairment

    Reduced efficacy for glucose lowering and increased risk of adverse events.

  • Type 1 Diabetes

    High risk of euglycemic ketoacidosis, which can be life threatening.

  • Liver Cirrhosis

    Use with caution due to potential for volume depletion and hypotension.

Effect on laboratory tests

  • Urine Glucose

    Increased

    Empagliflozin causes glucosuria, making urine glucose tests positive even if blood glucose is normal.

Quick tips

  • Drink plenty of water throughout the day to avoid dehydration and dizziness.
  • Maintain good genital hygiene to prevent yeast infections and urinary tract issues.
  • Check your blood sugar regularly as advised by your doctor to monitor the effect of Empagliflozin 25mg Tablet.
  • Tell your doctor immediately if you have a severe infection or feel very ill, as this can lead to ketoacidosis.

Counselling points

  • HydrationImportant

    Drink more water than usual to prevent dehydration.

  • KetoacidosisImportant

    Report nausea, vomiting, or abdominal pain immediately.

  • HygieneGood to know

    Wash the genital area daily to reduce the risk of infections.

  • Foot CareGood to know

    Check your feet daily for sores or infections.

Monitoring during treatment

Before starting

  • Serum creatinine
  • eGFR
  • Urine albumin-to-creatinine ratio
  • Blood pressure

During treatment

  • every 6 months: Repeat eGFR and serum creatinine tests

What is being watched

  • eGFR
  • Blood glucose
  • Blood pressure
  • Weight

Pharmacokinetics

Absorption
Rapidly absorbed after oral administration.
Bioavailability
Approximately 60%
Protein binding
86%
Volume of distribution
Not established
Half-life
12.4 hours
Metabolism
Primarily via glucuronidation by UGT enzymes.
Excretion
54% excreted in urine and 41% in feces.
Onset / duration
Onset is rapid with a duration of action lasting 24 hours.

Fact box

Chemical class
C-glycoside
Habit forming
No
Therapeutic class
Antidiabetic
Action class
Sodium-Glucose Co-transporter 2 Inhibitor
Storage
Store Empagliflozin 25mg Tablet at room temperature, away from moisture and heat. Keep the tablets in their original packaging and out of reach of children.
ATC code
A10BK29
Pregnancy category
C

More information

The Shift to Organ Protection

For decades, the primary goal of treating type 2 diabetes was simply to lower the HbA1c level. However, the introduction of Empagliflozin marked a shift toward organ protection. Clinical trials showed that this drug does more than just lower glucose. It provides a significant reduction in the risk of death from cardiovascular causes and prevents the worsening of heart failure. Clinicians now often prescribe Empagliflozin 25mg Tablet not just for its glucose lowering effect, but as a protective therapy for the heart and kidneys. This makes it a first line choice for patients who have a history of heart disease or chronic kidney disease, regardless of their baseline HbA1c.

Comparing SGLT2 Inhibitors

Empagliflozin is one of several SGLT2 inhibitors, including dapagliflozin and canagliflozin. While all these drugs work by blocking glucose reabsorption in the kidney, Empagliflozin has some of the strongest evidence for reducing cardiovascular death. Some clinicians prefer Empagliflozin 25mg Tablet because of the robust data from the EMPA-REG OUTCOME trial. While the differences in glucose lowering are modest between the drugs, the specific benefits for heart failure and kidney protection vary slightly. The choice between these agents often depends on the patient's specific comorbidities, such as the presence of heart failure with reduced ejection fraction.

Lifestyle and Dietary Synergy

Taking Empagliflozin 25mg Tablet requires certain lifestyle adjustments to maximize safety. Because the drug increases the amount of sugar in the urine, it creates a risk for fungal infections. Patients are advised to maintain meticulous genital hygiene. Furthermore, the diuretic effect of Empagliflozin means that water intake must be increased. A low carbohydrate diet complements the action of the drug, as it reduces the overall glucose load the kidneys must handle. Patients should also be taught about sick day rules, which involve pausing the medication during severe illness or fasting to prevent the onset of euglycemic ketoacidosis.

Patient Journey and Expectations

When starting Empagliflozin 25mg Tablet, patients should expect a few changes in the first few weeks. The most immediate effect is often an increase in the frequency of urination. This is a sign that the drug is working to remove glucose from the body. Over the first few months, patients typically see a gradual decline in their HbA1c and a modest reduction in weight. It is important to manage expectations, as this drug is not a rapid weight loss agent but a metabolic regulator. Long term success depends on combining the medication with a healthy diet and regular physical activity to maintain cardiovascular health.

References

  1. Electronic Medicines Compendium. Empagliflozin 10 mg tablets, Summary of Product Characteristics.View sourceAccessed
  2. European Medicines Agency. Jardiance product information.View sourceAccessed
  3. Rwanda FDA. Jardiance 10mg Tablets SmPC.View sourceAccessed
  4. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 13th ed. McGraw-Hill.Accessed
  5. Katzung B. Basic and Clinical Pharmacology. 14th ed. McGraw-Hill.Accessed
Also available as

Frequently asked questions about Empagliflozin

Will Empagliflozin 25mg Tablet cause weight loss?

Yes, Empagliflozin typically causes modest weight loss due to the loss of calories through glucose in the urine.

Does it cause hypoglycemia?

When used alone, Empagliflozin rarely causes low blood sugar. The risk increases if you use it with insulin or sulfonylureas.

Why do I urinate more?

The drug works by removing sugar through your urine, which pulls water with it, increasing urination.

Can I take it if I have kidney disease?

It is used in CKD, but your doctor will check your eGFR to ensure it is safe for your specific stage.

What is euglycemic ketoacidosis?

It is a rare condition where blood becomes acidic even if sugar levels seem normal. Seek urgent care if you feel ill.

Latest